title: Susceptibility of urinary tract bacteria to fosfomycin.
abstract: We evaluated the in vitro activity of fosfomycin against urinary isolates in a region in Greece that exhibits considerable antimicrobial resistance by evaluating retrospectively relevant susceptibility data retrieved from the microbiological library of the University Hospital of Heraklion, Crete, Greece. We examined 578 urinary isolates. In total, 516 (89.2%) were susceptible to fosfomycin; 415 isolates were gram negative, and 101 isolates were gram positive. Fosfomycin appears to exhibit good levels of in vitro activity against the examined urinary isolates.
authors.affiliation: Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, Crete, Greece.
authors.forename: Sofia
authors.initials: S
authors.lastname: Maraki
authors.forename: George
authors.initials: G
authors.lastname: Samonis
authors.forename: Petros I
authors.initials: PI
authors.lastname: Rafailidis
authors.forename: Evridiki K
authors.initials: EK
authors.lastname: Vouloumanou
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Mavromanolakis
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Falagas
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D005578:Fosfomycin / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D014551:Urinary Tract / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin
references.citation: Arch Intern Med. 2008 Sep 22;168(17):1897-902
references.pmid: 18809817
references.citation: Int J Antimicrob Agents. 2002 Jun;19(6):554-6
references.pmid: 12135847
references.citation: Ann Epidemiol. 2003 Feb;13(2):144-50
references.pmid: 12559674
references.citation: J Infect. 2008 Sep;57(3):179-84
references.pmid: 18707763
references.citation: Eur J Clin Microbiol Infect Dis. 2008 Jun;27(6):439-43
references.pmid: 18214558
references.citation: Rev Esp Quimioter. 2009 Mar;22(1):25-9
references.pmid: 19308743
references.citation: Presse Med. 2008 May;37(5 Pt 1):746-50
references.pmid: 18329234
references.citation: Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
references.pmid: 12113866
references.citation: Curr Opin Investig Drugs. 2009 Feb;10(2):172-80
references.pmid: 19197795
references.citation: Am J Med. 2008 Oct;121(10):876-84
references.pmid: 18823859
references.citation: Rev Invest Clin. 2007 Jul-Aug;59(4):239-45
references.pmid: 18019596
references.citation: Diagn Microbiol Infect Dis. 2007 Dec;59(4):439-45
references.pmid: 17888610
references.citation: J Urol. 2005 Apr;173(4):1281-7
references.pmid: 15758783
references.citation: Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:79-83
references.pmid: 14527776
references.citation: J Antimicrob Chemother. 2009 Sep;64(3):454-89
references.pmid: 19587067
references.citation: Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
references.pmid: 17630334
references.citation: Curr Med Res Opin. 2008 Dec;24(12):3423-34
references.pmid: 19032124
references.citation: Clin Infect Dis. 2008 Apr 1;46(7):1069-77
references.pmid: 18444827
references.citation: Int J Antimicrob Agents. 2009 Aug;34(2):111-20
references.pmid: 19403273
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):61-8
references.pmid: 18682995
references.citation: J Chemother. 2008 Dec;20(6):721-7
references.pmid: 19129070
references.citation: Ann Intern Med. 1989 Dec 1;111(11):906-17
references.pmid: 2683922
references.citation: J Antimicrob Chemother. 2006 Mar;57(3):551-6
references.pmid: 16436541
references.citation: Antimicrob Agents Chemother. 2006 Jan;50(1):368-70
references.pmid: 16377714
references.citation: Clin Infect Dis. 2008 Nov 1;47(9):1150-8
references.pmid: 18808361
references.citation: Clin Infect Dis. 1999 Oct;29(4):745-58
references.pmid: 10589881
references.citation: Ann Pharmacother. 1998 Feb;32(2):215-9
references.pmid: 9496408
references.citation: Obstet Gynecol. 2008 Mar;111(3):785-94
references.pmid: 18310389
references.citation: Drugs. 1997 Apr;53(4):637-56
references.pmid: 9098664
references.citation: Clin Ther. 2008 Oct;30(10):1859-68
references.pmid: 19014841
references.citation: Expert Opin Investig Drugs. 2009 Jul;18(7):921-44
references.pmid: 19548851
references.citation: Pol Przegl Chir. 1976 Dec;48(12):1491-4
references.pmid: 1005244
references.citation: Rev Esp Quimioter. 2007 Jun;20(2):206-10
references.pmid: 17893757
references.citation: Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):153-60
references.pmid: 18336741
references.citation: Pathol Biol (Paris). 2003 Oct;51(8-9):503-7
references.pmid: 14568598
references.citation: J Clin Microbiol. 2008 Aug;46(8):2605-12
references.pmid: 18579721
references.citation: Med Mal Infect. 2008 Jul;38(7):383-6
references.pmid: 18550311